OTC Markets OTCPK - Delayed Quote USD
Novartis AG (NVSEF)
111.41
0.00
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 16 | 17 |
| Avg. Estimate | 13.04B | 13.81B | 53.45B | 54.44B |
| Low Estimate | 12.86B | 13.55B | 52.11B | 50B |
| High Estimate | 13.17B | 14.24B | 55.86B | 58.33B |
| Year Ago Sales | 11.83B | 12.51B | 50.32B | 53.45B |
| Sales Growth (year/est) | 10.24% | 10.39% | 6.22% | 1.87% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVSEF | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
AZNCF AstraZeneca PLC
137.24
0.00%
RHHVF Roche Holding AG
318.68
+0.58%
RHHBF Roche Holding AG
355.38
0.00%
LLY.SG Eli Lilly and Co
759.80
+2.72%
RHO6.SG Roche Holding AG
33.96
-0.56%
GLAXF GSK plc
17.98
-2.60%
COPN.SW Cosmo Pharmaceuticals N.V.
47.35
+0.11%
LLY.MX Eli Lilly and Company
16,785.00
+4.25%
SNYNF Sanofi
106.45
0.00%
NONOF Novo Nordisk A/S
61.55
-3.15%